Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study systematically observes in a pragmatic trail under real world conditions the association between strategies of therapy (maximal therapy, withhold, withdraw) and treatment success in three endpoint related initial risk groups (high, intermediate, low risk) regarding three endpoints (burden, mortality and supply costs).
This study systematically observes in a pragmatic trail under real world conditions the association between strategies of therapy (maximal therapy, withhold, withdraw) and treatment success in three endpoint related initial risk groups (high, intermediate, low risk) regarding three endpoints (burden, mortality and supply costs).
The 3 endpoints and 3 respective risk groups (high, intermediate, low) are
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intensive care unit patient | All intensive care unit patients staying for at least 72 hours on the ICU and patients dying within 72 hours |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Burden of care | Organ dysfunctions supported or replaced in numbers | 18 months |
| Mortality | Dying patients in numbers | 18 months |
| Supply costs | Costs in sum of Simplified Acute Physiology Score (SAPS) II score points over ICU stay; Costs in sum of points of organ support over ICU stay; Costs in Euro reimbursed for the ICU stay | 18 months |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Critically ill patients admitted to the intensive care unit, mainly surgical and polytraumatized patients
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Manfred Weiss, MD, MBA | Contact | +49 - (0)731-500 | 60226 | manfred.weiss@uniklinik-ulm.de |
| Eberhard Barth, MD | Contact | +49 - (0)731-500 | 60233 | eberhard.barth@uniklinik-ulm.de |
| Name | Affiliation | Role |
|---|---|---|
| Manfred Weiss, MD, MBA | University Hospital Medical School | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Anaesthesiology, University Hospital Ulm | Recruiting | Ulm | 89075 | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000073496 | Frailty |
| D009102 | Multiple Organ Failure |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012769 | Shock |
Not provided
Not provided
Not provided
Not provided
Not provided